The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Donald F. Smee

Institute for Antiviral Research

Department of Animal

Dairy and Veterinary Sciences

Utah State University

USA

[email]@cc.usu.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, USA. 2000 - 2008
  • Institute for Antiviral Research, Utah State University, Logan, USA. 2000 - 2008
  • Department of Animal, Dairy, and Veterinary Sciences, Institute for Antiviral Research, USA. 2004
  • Virology Division, US Army Medical Research Institute of Infectious Diseases, Frederick, USA. 2001

References

  1. Progress in the discovery of compounds inhibiting orthopoxviruses in animal models. Smee, D.F. Antivir. Chem. Chemother. (2008) [Pubmed]
  2. Antiviral activities and phosphorylation of 5-halo-2'-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virus. Smee, D.F., Humphreys, D.E., Hurst, B.L., Barnard, D.L. Antivir. Chem. Chemother. (2008) [Pubmed]
  3. Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment. Smee, D.F., Gowen, B.B., Wandersee, M.K., Wong, M.H., Skirpstunas, R.T., Baldwin, T.J., Hoopes, J.D., Sidwell, R.W. Int. J. Antimicrob. Agents (2008) [Pubmed]
  4. Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N. Smee, D.F., Bailey, K.W., Wong, M.H., O'Keefe, B.R., Gustafson, K.R., Mishin, V.P., Gubareva, L.V. Antiviral Res. (2008) [Pubmed]
  5. Influenza A (H1N1) virus resistance to cyanovirin-N arises naturally during adaptation to mice and by passage in cell culture in the presence of the inhibitor. Smee, D.F., Wandersee, M.K., Checketts, M.B., O'Keefe, B.R., Saucedo, C., Boyd, M.R., Mishin, V.P., Gubareva, L.V. Antivir. Chem. Chemother. (2007) [Pubmed]
  6. Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in mice. Smee, D.F., Wandersee, M.K., Bailey, K.W., Wong, M.H., Chu, C.K., Gadthula, S., Sidwell, R.W. Antiviral Res. (2007) [Pubmed]
  7. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses. Smee, D.F., Wong, M.H., Bailey, K.W., Sidwell, R.W. Antivir. Chem. Chemother. (2006) [Pubmed]
  8. Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice. Smee, D.F., Wandersee, M.K., Bailey, K.W., Hostetler, K.Y., Holy, A., Sidwell, R.W. Antivir. Chem. Chemother. (2005) [Pubmed]
  9. Anti-cowpox virus activities of certain adenosine analogs, arabinofuranosyl nucleosides, and 2'-fluoro-arabinofuranosyl nucleosides. Smee, D.F., Sidwell, R.W. Nucleosides. Nucleotides. Nucleic. Acids (2004) [Pubmed]
  10. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice. Smee, D.F., Wong, M.H., Bailey, K.W., Beadle, J.R., Hostetler, K.Y., Sidwell, R.W. Int. J. Antimicrob. Agents (2004) [Pubmed]
  11. Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice. Smee, D.F., Bailey, K.W., Wong, M.H., Wandersee, M.K., Sidwell, R.W. J. Infect. Dis. (2004) [Pubmed]
  12. Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine. Smee, D.F., Wandersee, M.K., Wong, M.H., Bailey, K.W., Sidwell, R.W. Antivir. Chem. Chemother. (2004) [Pubmed]
  13. A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Smee, D.F., Sidwell, R.W. Antiviral Res. (2003) [Pubmed]
  14. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice. Smee, D.F., Bailey, K.W., Sidwell, R.W. Chemotherapy (2003) [Pubmed]
  15. Antiviral Research--16th International Congress: HBV and HCV. 27 April-1 May 2003, Savannah, GA, USA. Smee, D. IDrugs (2003) [Pubmed]
  16. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses. Smee, D.F., Sidwell, R.W., Kefauver, D., Bray, M., Huggins, J.W. Antimicrob. Agents Chemother. (2002) [Pubmed]
  17. Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin. Smee, D.F., Bailey, K.W., Morrison, A.C., Sidwell, R.W. Chemotherapy (2002) [Pubmed]
  18. Antiviral Research - 15th International Conference. HBV and HCV therapies. 17-21 March 2002, Prague, Czech Republic. Smee, D.F. IDrugs (2002) [Pubmed]
  19. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Smee, D.F., Huffman, J.H., Morrison, A.C., Barnard, D.L., Sidwell, R.W. Antimicrob. Agents Chemother. (2001) [Pubmed]
  20. Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir. Smee, D.F., Bailey, K.W., Sidwell, R.W. Antivir. Chem. Chemother. (2001) [Pubmed]
  21. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Smee, D.F., Bailey, K.W., Wong, M.H., Sidwell, R.W. Antiviral Res. (2001) [Pubmed]
  22. Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201. Smee, D.F., Sidwell, R.W., Morrison, A.C., Bailey, K.W., Baum, E.Z., Ly, L., Wagaman, P.C. Antiviral Res. (2001) [Pubmed]
  23. Intracellular phosphorylation of carbocyclic 3-deazaadenosine, an anti-Ebola virus agent. Smee, D.F., Bray, M., Huggins, J.W. Antivir. Chem. Chemother. (2001) [Pubmed]
  24. Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro. Smee, D.F., Bray, M., Huggins, J.W. Antivir. Chem. Chemother. (2001) [Pubmed]
  25. Antiviral Research. Hepatitis viruses. Smee, D.F. IDrugs (2001) [Pubmed]
  26. Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir. Smee, D.F., Bailey, K.W., Sidwell, R.W. Antivir. Chem. Chemother. (2000) [Pubmed]
  27. Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir. Smee, D.F., Bailey, K.W., Wong, M., Sidwell, R.W. Antiviral Res. (2000) [Pubmed]
  28. Antiviral Research. Antiviral targets. Smee, D.F. IDrugs (2000) [Pubmed]
 
WikiGenes - Universities